Results 61 to 70 of about 4,142 (135)

The Effect of Brimonidine 0.1% on Disc Hemorrhage in Primary Open-Angle Glaucoma Patients

Clinical Ophthalmology, 2020
Koji Nitta,1,2 Shiro Shimamoto,3 Ryotaro Wajima,2 Gaku Tachibana,2 Yutaro Yamada,1,2 Miyuki Domoto,1 Ryuji Takeda,4,5 Yoshinari Takahashi,6 Kazuhisa Sugiyama2 1Fukui-ken Saiseikai Hospital, Fukui, Japan; 2Department of Ophthalmology, Kanazawa University ...
Nitta K, Shimamoto S, Wajima R, Tachibana G, Yamada Y, Domoto M, Takeda R, Takahashi Y, Sugiyama K   +8 more
doaj  

Twelve-week, randomized, multicenter study comparing a fixed combination of brimonidine-timolol with timolol as therapy adjunctive to latanoprost

Clinical Ophthalmology, 2011
Robert D Fechtner1, Paul Harasymowycz2, Donald R Nixon3, Steven D Vold4, Fiaz Zaman5, Julia M Williams6, David A Hollander61Glaucoma Division, University of Medicine and Dentistry New Jersey, Newark, NJ, USA; 2University of Montreal, Montreal, QC, Canada;
Fechtner RD, Harasymowycz P, Nixon DR, Vold SD, Zaman F, Williams JM, Hollander DA   +6 more
doaj  

Brimonidine Eye Drops within the Reach of Children: A Possible Foe

Children
Brimonidine, a selective alpha-2 adrenergic agonist used for the treatment of open-angle glaucoma, has been shown to cause neurological side effects such as unresponsiveness, lethargy, hypoventilation, and stupor, mimicking opioid toxicity. We report one
Daniela Trotta, Mirco Zucchelli, Carmela Salladini, Patrizia Ballerini, Claudia Rossi, Maurizio Aricò   +5 more
doaj   +1 more source

Clinical efficacy and neuroprotective effects of brimonidine in the management of glaucoma and ocular hypertension

Clinical Ophthalmology, 2008
Anna Galanopoulos1, Ivan Goldberg21Senior Visiting Ophthalmologist, South Australian Institute of Ophthalmology and Dept of Ophthalmology and Visual Sciences, University of Adelaide, South Australia; 2Clinical Associate Professor, University of Sydney ...
Anna Galanopoulos, Ivan Goldberg
doaj  

The potential of brimonidine for myopia treatment: Targeting MMP-2 to regulate choroidal thickness and control eye growth

Heliyon
Drug treatment studies are a focal point for identifying novel approaches to reduce myopia progression through basic science research. Here, we investigated the effects of various brimonidine administration routes and concentrations on form-deprivation ...
Aiqun Xiang, Zixuan Peng, Hong He, Xuyun Meng, Yanting Luo, Junming Yang, Fang Zeng, Xiaolian Chen, Xingwu Zhong   +8 more
doaj   +1 more source

Fixed combination of topical brimonidine 0.2% and timolol 0.5% for glaucoma and uncontrolled intraocular pressure

Clinical Ophthalmology, 2008
Anne J Lee1, Peter McCluskey1,21Department of Ophthalmology, Liverpool Hospital, Liverpool, NSW, Australia; 2Faculty of Medicine, University of New South Wales, Randwick, NSW, AustraliaAbstract: Lowering IOP is the most readily modifiable risk factor to ...
Anne J Lee, Peter McCluskey
doaj  

Modification of contact lenses via metal‐organic frameworks for glaucoma treatment

Aggregate
The prevention of blindness from glaucoma requires multiple treatments to lower intraocular pressure. Here, human contact lenses are modified with highly porous metal‐organic frameworks with sustained release of brimonidine for prolonged glaucoma ...
Alexey V. Yaremenko, Roman O. Melikov, Nadezhda A. Pechnikova, Iaroslav B. Belyaev, Alina Ringaci, Tamara V. Yaremenko, Aziz B. Mirkasymov, Alexandr A. Tamgin, Vladislav I. Rodionov, Sofya M. Dolotova, Grigory A. Plisko, Evgeny D. Semivelichenko, Anna S. Rogova, Albert R. Muslimov, Arina S. Ivkina, Dmitry Yu. Ivkin, Valery P. Erichev, Sergey M. Deyev, Sergey E. Avetisov, Yongjiang Li, Hai‐Jun Liu, Ivan V. Zelepukin   +21 more
doaj   +1 more source

BRIMONIDINE EFFICACY ON INTRAOCULAR PRESSURE CONTROL FOLLOWING ND: YAG LASER CAPSULOTOMY

Pakistan Armed Forces Medical Journal, 2018
Objective: To determine the efficacy of 0.2% brimonidine eye drops on control of intraocular pressure following Neodymium: Yttrium-Aluminum-Garnet (Nd: YAG) laser posterior capsulotomy. Study Design: Quasi experimental study.
Muhammad Asaad Saleem, Muhammad Manzoor, Asim Shehzad, Muhammad Ramzan, Saliha Hafeez   +4 more
doaj  

Perspectives of Healthcare Professionals on the Treatment Landscape of Ocular Redness. [PDF]

Patient Prefer Adherence
Toyos MM, Forster K, Savar S, Aguado S, Kiskiras K, Akbas E, DiVito M, Ryan R, Gallop K, Boboridis K, Salgado-Borges JM, Alio JL.   +11 more
europepmc   +1 more source

Brimonidine Beyond a Single Specialty: Pharmacological Profile, Dermatologic Applications, and Advances in Drug Delivery Systems. [PDF]

Int J Mol Sci
Jóźwiak W, Pietrusiewicz M, Piechota-Urbańska M, Markowicz-Piasecka M.   +3 more
europepmc   +1 more source